Answers are grounded in this paper and cite their sources.
Clostridium difficile infection (CDI) has become more refractory to standard therapy. We describe 4 patients with severe refractory CDI who were successfully treated with tigecycline. Symptoms improved within 1 week. No relapses were observed. This favorable outcome suggests that tigecycline might be a useful alternative for treating severe refractory CDI.
No takes yet. Share an insight, caveat, or question.
Herpers et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: